Veeva Systems Cash Flow from Investing Activities 2012-2025 | VEEV

Veeva Systems annual/quarterly cash flow from investing activities history and growth rate from 2012 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Veeva Systems cash flow from investing activities for the quarter ending April 30, 2025 was $-0.052B, a 80.87% decline year-over-year.
  • Veeva Systems cash flow from investing activities for the twelve months ending April 30, 2025 was $-1.823B, a 43.99% decline year-over-year.
  • Veeva Systems annual cash flow from investing activities for 2025 was $-0.7B, a 34.95% decline from 2024.
  • Veeva Systems annual cash flow from investing activities for 2024 was $-1.076B, a 6.81% increase from 2023.
  • Veeva Systems annual cash flow from investing activities for 2023 was $-1.008B, a 191.11% increase from 2022.
Veeva Systems Annual Cash Flow Investing
(Millions of US $)
2025 $-700
2024 $-1,076
2023 $-1,008
2022 $-346
2021 $-334
2020 $-517
2019 $-104
2018 $-155
2017 $-97
2016 $-97
2015 $-272
2014 $-27
2013 $-16
2012 $-2
2011 $-1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $46.313B $2.747B
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data).
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.516B 0.00
Doximity (DOCS) United States $11.474B 53.12
Hims & Hers Health (HIMS) United States $11.060B 114.91
IRhythm Technologies (IRTC) United States $4.939B 0.00
Inspire Medical Systems (INSP) United States $3.905B 61.02
Hinge Health (HNGE) United States $3.629B 0.00
Privia Health (PRVA) United States $2.682B 183.33
Enovis (ENOV) United States $1.815B 10.12
Phreesia (PHR) United States $1.695B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
10x Genomics (TXG) United States $1.444B 0.00
Clover Health Investments (CLOV) United States $1.405B 0.00
Azenta (AZTA) United States $1.400B 65.08
Omnicell (OMCL) United States $1.376B 24.28
Evolent Health (EVH) United States $1.310B 111.60
Claritev (CTEV) United States $0.716B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.485B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.452B 0.00
TruBridge (TBRG) United States $0.349B 773.33
Outset Medical (OM) United States $0.338B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.124B 0.00
MDxHealth SA (MDXH) Belgium $0.109B 0.00
Pulmonx (LUNG) United States $0.105B 0.00
CareCloud (CCLD) United States $0.102B 3.89
Insight Molecular Diagnostics (IMDX) United States $0.092B 0.00
111 (YI) China $0.060B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.051B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00